The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Tricyclic Compounds - EP2506716

The patent EP2506716 was granted to Abbott on May 17, 2017. The application was filed on Dec 1, 2010 under application number EP10835061A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2506716

ABBOTT
Application Number
EP10835061A
Filing Date
Dec 1, 2010
Status
Opposition Rejected
Nov 22, 2019
Publication Date
May 17, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKFeb 16, 2018TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2123651
DESCRIPTIONUS2007293509
DESCRIPTIONUS2008248537
DESCRIPTIONUS6090382
DESCRIPTIONWO2006058120
DESCRIPTIONWO2007007919
DESCRIPTIONWO2007014011
DESCRIPTIONWO2007077949
DESCRIPTIONWO2008004117
DESCRIPTIONWO2009018238
DESCRIPTIONWO2009152133
INTERNATIONAL-SEARCH-REPORTWO2005110410
INTERNATIONAL-SEARCH-REPORTWO2008063287
INTERNATIONAL-SEARCH-REPORTWO2009005675
INTERNATIONAL-SEARCH-REPORTWO2009152133
OPPOSITIONWO2009152133
SEARCHEP2123651
SEARCHWO2007007919
SEARCHWO2007077949
SEARCHWO2010119875

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents